These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 33318498)
1. PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells. Witte KE; Slotta C; Lütkemeyer M; Kitke A; Coras R; Simon M; Kaltschmidt C; Kaltschmidt B Sci Rep; 2020 Dec; 10(1):21858. PubMed ID: 33318498 [TBL] [Abstract][Full Text] [Related]
2. Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Kitange GJ; Carlson BL; Schroeder MA; Grogan PT; Lamont JD; Decker PA; Wu W; James CD; Sarkaria JN Neuro Oncol; 2009 Jun; 11(3):281-91. PubMed ID: 18952979 [TBL] [Abstract][Full Text] [Related]
3. MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients? Della Puppa A; Persano L; Masi G; Rampazzo E; Sinigaglia A; Pistollato F; Denaro L; Barzon L; Palù G; Basso G; Scienza R; d'Avella D J Neurooncol; 2012 Jan; 106(1):33-41. PubMed ID: 21725802 [TBL] [Abstract][Full Text] [Related]
4. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents. Szeliga M; Zgrzywa A; Obara-Michlewska M; Albrecht J J Neurochem; 2012 Nov; 123(3):428-36. PubMed ID: 22888977 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status. Patyka M; Sharifi Z; Petrecca K; Mansure J; Jean-Claude B; Sabri S Oncotarget; 2016 Sep; 7(37):60245-60269. PubMed ID: 27533246 [TBL] [Abstract][Full Text] [Related]
7. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas. He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436 [TBL] [Abstract][Full Text] [Related]
8. miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma. Khalil S; Fabbri E; Santangelo A; Bezzerri V; Cantù C; Di Gennaro G; Finotti A; Ghimenton C; Eccher A; Dechecchi M; Scarpa A; Hirshman B; Chen C; Ferracin M; Negrini M; Gambari R; Cabrini G Oncotarget; 2016 May; 7(19):28195-206. PubMed ID: 27057640 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Pistollato F; Abbadi S; Rampazzo E; Persano L; Della Puppa A; Frasson C; Sarto E; Scienza R; D'avella D; Basso G Stem Cells; 2010 May; 28(5):851-62. PubMed ID: 20309962 [TBL] [Abstract][Full Text] [Related]
10. Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells. Taspinar M; Ilgaz S; Ozdemir M; Ozkan T; Oztuna D; Canpinar H; Rey JA; Sunguroğlu A; Castresana JS; Ugur HC Tumour Biol; 2013 Jun; 34(3):1935-47. PubMed ID: 23519841 [TBL] [Abstract][Full Text] [Related]
11. BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53. Nie E; Jin X; Wu W; Yu T; Zhou X; Zhi T; Shi Z; Zhang J; Liu N; You Y Sci Rep; 2016 Dec; 6():39743. PubMed ID: 28000777 [TBL] [Abstract][Full Text] [Related]
12. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells. Happold C; Roth P; Wick W; Schmidt N; Florea AM; Silginer M; Reifenberger G; Weller M J Neurochem; 2012 Jul; 122(2):444-55. PubMed ID: 22564186 [TBL] [Abstract][Full Text] [Related]
13. Plekhg5-regulated autophagy of synaptic vesicles reveals a pathogenic mechanism in motoneuron disease. Lüningschrör P; Binotti B; Dombert B; Heimann P; Perez-Lara A; Slotta C; Thau-Habermann N; R von Collenberg C; Karl F; Damme M; Horowitz A; Maystadt I; Füchtbauer A; Füchtbauer EM; Jablonka S; Blum R; Üçeyler N; Petri S; Kaltschmidt B; Jahn R; Kaltschmidt C; Sendtner M Nat Commun; 2017 Oct; 8(1):678. PubMed ID: 29084947 [TBL] [Abstract][Full Text] [Related]
14. Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O Dehghani-Soltani S; Eftekhar-Vaghefi SH; Babaee A; Basiri M; Mohammadipoor-Ghasemabad L; Vosough P; Ahmadi-Zeidabadi M Cancer Biother Radiopharm; 2021 Sep; 36(7):579-587. PubMed ID: 32644826 [No Abstract] [Full Text] [Related]
15. Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma. Nie E; Miao F; Jin X; Wu W; Zhou X; Zeng A; Yu T; Zhi T; Shi Z; Wang Y; Zhang J; Liu N; You Y Oncogene; 2019 Apr; 38(15):2706-2721. PubMed ID: 30542120 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. Shah N; Lin B; Sibenaller Z; Ryken T; Lee H; Yoon JG; Rostad S; Foltz G PLoS One; 2011 Jan; 6(1):e16146. PubMed ID: 21249131 [TBL] [Abstract][Full Text] [Related]